Patents by Inventor Mitchell Shirvan

Mitchell Shirvan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods for treating rosacea and acne
    Patent number: 11324691
    Abstract: Provided are compositions and methods for treating rosacea and acne. Specifically, a gel or foam composition having a tetracycline antibiotic and uses thereof for treating rosacea and acne are provided.
    Type: Grant
    Filed: October 20, 2020
    Date of Patent: May 10, 2022
    Assignee: Journey Medical Corporation
    Inventors: Dov Tamarkin, Meir Eini, Yohan Hazot, Mitchell Shirvan, Tal Hetzroni Kedem, Rita Keynan
  • COMPOSITIONS AND METHODS FOR TREATING ROSACEA AND ACNE
    Publication number: 20210205212
    Abstract: Provided are compositions and methods for treating rosacea and acne. Specifically, a gel or foam composition having a tetracycline antibiotic and uses thereof for treating rosacea and acne are provided.
    Type: Application
    Filed: October 20, 2020
    Publication date: July 8, 2021
    Inventors: Dov Tamarkin, Meir Eini, Yohan Hazot, Mitchell Shirvan, Tal Hetzroni Kedem, Rita Keynan
  • Formation of stable cartilage
    Patent number: 10940241
    Abstract: Methods are provided for promoting cartilage growth and/or repair. The methods include, administering locally to a site in a subject in need thereof, bone marrow stromal cells attached to fibrin microbeads comprising crosslinked hyaluronic acid and thereby producing stable cartilage locally at the site in the subject.
    Type: Grant
    Filed: May 31, 2018
    Date of Patent: March 9, 2021
    Assignees: The United States of America, as represented by the Secretary, Department of Health and Human Services, Hadasit Medical Research Services and Development Ltd.
    Inventors: Pamela Gehron Robey, Sergei Kuznetsov, Raphael Gorodetsky, Astar Hailu-Lazmi, Mitchell Shirvan, Joseph Featherall
  • TETRACYCLINE MANAGEMENT OF EGFR INHIBITOR ASSOCIATED DERMATOSES
    Publication number: 20210000842
    Abstract: Methods of treatment and dosage regimes using a composition comprising a tetracycline antibiotic in treating or alleviating a disorder including EGFRI associated rash, EGFRI associated rash related symptoms, a tetracycline antibiotic responsive EGFRI associated rash related disorder, skin disorder caused by a bacteria, and a tetracycline antibiotic responsive sebaceous gland disease, P. EGFRI associated rash bacteria associated disorders and other superficial infections, including skin infections are provided.
    Type: Application
    Filed: September 15, 2020
    Publication date: January 7, 2021
    Inventors: Meir EINI, Mitchell SHIRVAN, Rita KEYNAN, Tal BERMAN, David SCHUZ, Yohan HAZOT
  • Compositions and methods for treating rosacea and acne
    Patent number: 10849847
    Abstract: Provided are compositions and methods for treating rosacea and acne. Specifically, a gel or foam composition having a tetracycline antibiotic and uses thereof for treating rosacea and acne are provided.
    Type: Grant
    Filed: July 11, 2019
    Date of Patent: December 1, 2020
    Assignee: Foamix Pharamaceuticals Ltd.
    Inventors: Dov Tamarkin, Meir Eini, Yohan Hazot, Mitchell Shirvan, Tal Hetzroni Kedem, Rita Keynan
  • FORMATION OF STABLE CARTILAGE
    Publication number: 20200171215
    Abstract: Methods are provided for promoting cartilage growth and/or repair. The methods include, administering locally to a site in a subject in need thereof, bone marrow stromal cells attached to fibrin microbeads comprising crosslinked hyaluronic acid and thereby producing stable cartilage locally at the site in the subject.
    Type: Application
    Filed: May 31, 2018
    Publication date: June 4, 2020
    Applicants: THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH & HUMAN SERVICES, HADASIT MEDICAL RESEARCH SERVICES AND DEVELOPMENT LTD.
    Inventors: Pamela Gehron Robey, Sergei Kuznetsov, Raphael Gorodetsky, Astar Hailu-Lazmi, Mitchell Shirvan, Joseph Featherall
  • COMPOSITIONS AND METHODS FOR TREATING ROSACEA AND ACNE
    Publication number: 20200016068
    Abstract: Provided are compositions and methods for treating rosacea and acne. Specifically, a gel or foam composition having a tetracycline antibiotic and uses thereof for treating rosacea and acne are provided.
    Type: Application
    Filed: July 11, 2019
    Publication date: January 16, 2020
    Inventors: Dov Tamarkin, Meir Eini, Yohan Hazot, Mitchell Shirvan, Tal Hetzroni Kedem, Rita Keynan
  • TETRACYCLINE MANAGEMENT OF EGFR INHIBITOR ASSOCIATED DERMATOSES
    Publication number: 20190307778
    Abstract: Methods of treatment and dosage regimes using a composition comprising a tetracycline antibiotic in treating or alleviating a disorder including EGFRI associated rash, EGFRI associated rash related symptoms, a tetracycline antibiotic responsive EGFRI associated rash related disorder, skin disorder caused by a bacteria, and a tetracycline antibiotic responsive sebaceous gland disease, P. EGFRI associated rash bacteria associated disorders and other superficial infections, including skin infections are provided.
    Type: Application
    Filed: March 14, 2019
    Publication date: October 10, 2019
    Inventors: Meir EINI, Mitchell SHIRVAN, Rita KEYNAN, Tal BERMAN, David SCHUZ, Yohan HAZOT
  • Compositions and methods for treating rosacea and acne
    Patent number: 10398641
    Abstract: Provided are compositions and methods for treating rosacea and acne. Specifically, a gel or foam composition having a tetracycline antibiotic and uses thereof for treating rosacea and acne are provided.
    Type: Grant
    Filed: September 8, 2017
    Date of Patent: September 3, 2019
    Assignee: Foamix Pharmaceuticals Ltd.
    Inventors: Dov Tamarkin, Meir Eini, Yohan Hazot, Mitchell Shirvan, Tal Hetzroni Kedem, Rita Keynan
  • TETRACYCLINE MANAGEMENT OF EGFR INHIBITOR ASSOCIATED DERMATOSES
    Publication number: 20180235984
    Abstract: Methods of treatment and dosage regimes using a composition comprising a tetracycline antibiotic in treating or alleviating a disorder including EGFRI associated rash, EGFRI associated rash related symptoms, a tetracycline antibiotic responsive EGFRI associated rash related disorder, skin disorder caused by a bacteria, and a tetracycline antibiotic responsive sebaceous gland disease, P. EGFRI associated rash bacteria associated disorders and other superficial infections, including skin infections are provided.
    Type: Application
    Filed: August 19, 2016
    Publication date: August 23, 2018
    Applicant: Foamix Pharmaceuticals Ltd.
    Inventors: Meir EINI, Mitchell SHIRVAN, Rita KEYNAN, Tal BERMAN, David SCHUZ, Yohan HAZOT
  • COMPOSITIONS AND METHODS FOR TREATING ROSACEA AND ACNE
    Publication number: 20180064638
    Abstract: Provided are compositions and methods for treating rosacea and acne. Specifically, a gel or foam composition having a tetracycline antibiotic and uses thereof for treating rosacea and acne are provided.
    Type: Application
    Filed: September 8, 2017
    Publication date: March 8, 2018
    Inventors: Dov Tamarkin, Meir Eini, Yohan Hazot, Mitchell Shirvan, Tal Hetzroni Kedem, Rita Keynan
  • Activated leukocyte conditioned supernatant and uses for wound healing
    Patent number: 9439950
    Abstract: Disclosed are therapeutic, activated leukocyte conditioned supernatants, methods of making them, and methods of using the conditioned supernatants to repair or promote healing of wounds.
    Type: Grant
    Filed: September 14, 2015
    Date of Patent: September 13, 2016
    Assignee: MacroCure, Ltd.
    Inventors: Mitchell Shirvan, Eilat Bain, Marina Bubis, Irene Ginis
  • ACTIVATED LEUKOCYTE CONDITIONED SUPERNATANT AND USES FOR WOUND HEALING
    Publication number: 20160089420
    Abstract: Disclosed are therapeutic, activated leukocyte conditioned supernatants, methods of making them, and methods of using the conditioned supernatants to repair or promote healing of wounds.
    Type: Application
    Filed: September 14, 2015
    Publication date: March 31, 2016
    Applicant: MACROCURE LTD.
    Inventors: Mitchell Shirvan, Eilat Bain, Marina Bubis, Irene Ginis
  • ACTIVATED LEUKOCYTE COMPOSITION AND USES FOR WOUND HEALING
    Publication number: 20150352151
    Abstract: Disclosed are therapeutic, blood-derived activated leukocyte compositions, methods of making them, and methods of using the compositions to repair or promote the prevention and healing of wounds.
    Type: Application
    Filed: June 23, 2015
    Publication date: December 10, 2015
    Applicant: MACROCURE LTD.
    Inventors: Mitchell SHIRVAN, Eilat SHINAR, Orit FRENKEL, Adi ZULOFF-SHANI, Marina BUBIS, Eilat BAIN, Irene GINIS
  • Activated leukocyte conditioned supernatant and uses for wound healing
    Patent number: 9168287
    Abstract: Disclosed are therapeutic, activated leukocyte conditioned supernatants, methods of making them, and methods of using the conditioned supernatants to repair or promote healing of wounds.
    Type: Grant
    Filed: September 8, 2011
    Date of Patent: October 27, 2015
    Assignee: MacroCure, Ltd.
    Inventors: Mitchell Shirvan, Eilat Bain, Marina Bubis, Irene Ginis
  • Activated leukocyte composition and uses for wound healing
    Patent number: 9132154
    Abstract: Disclosed are therapeutic, blood-derived activated leukocyte compositions, methods of making them, and methods of using the compositions to repair or promote the prevention and healing of wounds.
    Type: Grant
    Filed: September 3, 2013
    Date of Patent: September 15, 2015
    Assignee: Macrocure Ltd.
    Inventors: Mitchell Shirvan, Eilat Shinar, Orit Frenkel, Adi Zuloff-Shani, Marina Bubis, Eilat Bain, Irene Gillis
  • Activated Immunostimulatory Cell Composition for Therapy of Infection
    Publication number: 20150071892
    Abstract: Methods of making activated immunostimulatory cell compositions, activated immunostimulatory cell compositions, and methods of using those compositions to stimulate therapeutic immune response to infectious organisms are described.
    Type: Application
    Filed: March 13, 2013
    Publication date: March 12, 2015
    Inventors: Irene Ginis, Alan Smith, Marina Bubis, Mitchell Shirvan
  • Activated Immunostimulatory Cell Composition and Uses Thereof
    Publication number: 20150030635
    Abstract: Methods of making activated immunostimulatory cell compositions, activated immunostimulatory cell compositions, and methods of using those compositions to stimulate therapeutic immune responses to tumors are described.
    Type: Application
    Filed: March 13, 2013
    Publication date: January 29, 2015
    Inventors: Irene Ginis, Alan Smith, Adi Zuloff-Shani, Marina Bubis, Mitchell Shirvan
  • Activated Leukocyte Composition and Uses For Wound Healing
    Publication number: 20140004091
    Abstract: Disclosed are therapeutic, blood-derived activated leukocyte compositions, methods of making them, and methods of using the compositions to repair or promote the prevention and healing of wounds.
    Type: Application
    Filed: September 3, 2013
    Publication date: January 2, 2014
    Applicant: Macrocure Ltd.
    Inventors: Mitchell Shirvan, Eilat Shinar, Orit Frenkel, Adi Zuloff-Shani, Marina Bubis, Eilat Bain, Irene Gillis
  • Activated leukocyte composition and uses for wound healing
    Patent number: 8574902
    Abstract: Disclosed are therapeutic, blood-derived activated leukocyte compositions, methods of making them, and methods of using the compositions to repair or promote the prevention and healing of wounds.
    Type: Grant
    Filed: September 2, 2011
    Date of Patent: November 5, 2013
    Assignee: Macrocure Ltd.
    Inventors: Mitchell Shirvan, Eilat Shinar, Orit Frenkel, Adi Zuloff-Shani, Marina Bubis, Eilat Bain, Irene Ginis